Pegasus Pharmaceuticals Inc.
4440 PGA Blvd. suite 308
Palm Beach Gardens
9 articles about Pegasus Pharmaceuticals Inc.
Several biopharma companies are closing out the month of April with expansions to facilities, including a $3 billion investment to develop next-generation life science ecosystems.
Pegasus Pharmaceuticals Inc. Invited to Present at Parenteral Drug Association Fungal Contamination Control Conferences
Pegasus Pharmaceuticals Inc. Release: Clinical Studies Completed for HeartVue's 6S Heart Screening System
Pegasus Pharmaceuticals Inc. Files Patents on New Biological Toxic Mold Control Product, Opens Lab & Appoints Distributor for Marketing to Multi-Billion Dollar Worldwide Mold Removal Market
Pegasus Pharmaceuticals Inc. Acquires Worldwide Marketing Rights To Effective Biological-Concept Mold Remove System -- Laboratory Tests Successfully Completed
Pegasus Pharmaceuticals Inc. And HeartView Delivers First Shipment Of 55 HeartVue 6S System Electrocardiograph Units To China
Pegasus Pharmaceuticals Inc.' HeartVue 6S System Successfully Demonstrated To Cardiologists At American College of Cardiology 55th Scientific Session Exposition In Atlanta
Pegasus Pharmaceuticals Inc./Heartview Signs Multi-Year Sales Agreement For China For Ground-Breaking HeartVue(TM) 6C System Technology